相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management
Alessandra Vultaggio et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Delving Deeper into Marker Development
Josh P. Roberts
Genetic Engineering & Biotechnology News (2011)
Classification and Characterization of Therapeutic Antibody Aggregates
Marisa K. Joubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions
Quanzhou Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Glass Particles as an Adjuvant: A Model for Adverse Immunogenicity of Therapeutic Proteins
Amber Haynes Fradkin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Satish Kumar Singh
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Antibody-based therapeutics to watch in 2011
Janice M. Reichert
MABS (2011)
Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development
John den Engelsman et al.
PHARMACEUTICAL RESEARCH (2011)
Immunogenicity of Therapeutic Proteins: The Use of Animal Models
Vera Brinks et al.
PHARMACEUTICAL RESEARCH (2011)
Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
Danika Wullner et al.
CLINICAL IMMUNOLOGY (2010)
An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein Therapeutics
Satish K. Singh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Antibodies to watch in 2010
Janice M. Reichert
MABS (2010)
Immunogenicity of Aggregates of Recombinant Human Growth Hormone in Mouse Models
Amber Haynes Fradkin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Protein Aggregation: Pathways, Induction Factors and Analysis
Hanns-Christian Mahler et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality
John F. Carpenter et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Shaken, not stirred: Mechanical stress testing of an IgG1 antibody
Sylvia Kiese et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
New Approaches to Prediction of Immune Responses to Therapeutic Proteins during Preclinical Development
Laura C. A. Perry et al.
DRUGS IN R&D (2008)
Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells
Evangelina A. Laborde et al.
JOURNAL OF IMMUNOLOGY (2007)
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization
Jerome Denis et al.
VIROLOGY (2007)
Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays
Amer Jaber et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
A role for protein misfolding in immunogenicity of biopharmaceuticals
Coen Maas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
Birgit M. Reipert et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Influence of aggregation on immunogenicity of recombinant human factor VIII in hemophilia A mice
VS Purohit et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Where disease pathogenesis meets protein formulation: Renal deposition of immunoglobulin aggregates
B Demeule et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Pathogen recognition and development of particulate vaccines: Does size matter?
Sue D. Xiang et al.
METHODS (2006)
Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2005)
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells
SR Krutzik et al.
NATURE MEDICINE (2005)
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
GL Morefield et al.
VACCINE (2005)
Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines
DB Corry et al.
FASEB JOURNAL (2004)
Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response
M Magi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
Aggregate content influences the Thl/Th2 immune response to influenza vaccine: Evidence from a mouse model
S Babiuk et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro
AF Popi et al.
IMMUNOLOGY (2004)
Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology
SC Higgins et al.
JOURNAL OF IMMUNOLOGY (2003)
Correlation of rFVIII inactivation with aggregation in solution
W Wang et al.
PHARMACEUTICAL RESEARCH (2003)
Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an Fc gamma RII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE
J Ronnelid et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
H Schellekens
CLINICAL THERAPEUTICS (2002)
Bioequivalence and the immunogenicity of biopharmaceuticals
H Schellekens
NATURE REVIEWS DRUG DISCOVERY (2002)
Immunogenicity of rDNA-derived pharmaceuticals
JC Ryff et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres
S Prior et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
FcγRIII mediates neutrophil recruitment to immune complexes:: A mechanism for neutrophil accumulation in immune-mediated inflammation
A Coxon et al.
IMMUNITY (2001)
Microbial lipopeptides stimulate dendritic cell maturation via toll-like receptor 2
CJ Hertz et al.
JOURNAL OF IMMUNOLOGY (2001)
The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes
Y Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
